VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 19.04
-0.06 (-0.31%)
Sep 18, 2026, 4:08 PM HKT
VISEN Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -239.51 | -253.42 | -182.24 | -249.57 | -288.97 |
Depreciation & Amortization | 3.6 | 3.17 | 4.47 | 6.15 | 6.67 |
Other Amortization | - | - | - | 0.85 | 0.72 |
Loss (Gain) From Sale of Assets | - | -0.72 | - | 0.24 | 0.09 |
Stock-Based Compensation | 58.8 | 76.36 | 32.77 | -12.27 | 93.51 |
Other Operating Activities | 3.69 | 1.1 | 2.48 | 67.12 | -0.77 |
Change in Accounts Receivable | -34.9 | -0.17 | - | - | - |
Change in Inventory | -55.95 | -1.53 | - | - | - |
Change in Accounts Payable | 2.31 | -3.26 | 1.21 | -12.08 | 4.44 |
Change in Unearned Revenue | - | - | -2.9 | - | - |
Change in Other Net Operating Assets | -196.14 | -269.11 | 3.36 | -71.75 | -62.25 |
Operating Cash Flow | -458.1 | -447.58 | -140.86 | -271.31 | -246.55 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -1.84 | -1.49 | -0.12 | -0.52 | -1.48 |
Sale (Purchase) of Intangibles | -1.29 | 8.16 | - | - | -0.28 |
Investing Cash Flow | -3.13 | 6.67 | -0.12 | -0.52 | -1.77 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Short-Term Debt Issued | - | 170 | - | - | - |
Total Debt Issued | 170 | 170 | - | - | - |
Long-Term Debt Repaid | - | -2 | -3.09 | -4.95 | -5.78 |
Lease Payments | -2.5 | -2 | -3.09 | -4.95 | -5.78 |
Net Debt Issued (Repaid) | 167.5 | 168 | -3.09 | -4.95 | -5.78 |
Issuance of Common Stock | - | 723.21 | - | - | - |
Other Financing Activities | -5.98 | -21.21 | - | -2.01 | -2.17 |
Financing Cash Flow | 161.52 | 870 | -3.09 | -6.95 | -7.95 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | -0.4 | -0.03 | -0.13 | 0.11 | 0.07 |
Net Cash Flow | -300.1 | 429.06 | -144.2 | -278.68 | -256.2 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -459.94 | -449.07 | -140.98 | -271.83 | -248.03 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -1995.31% | -330200.00% | -5076.52% | - | - |
Free Cash Flow Per Share | -4.24 | -4.33 | -1.51 | -2.90 | - |
Levered Free Cash Flow | -348.72 | -366.73 | -63.57 | -67.66 | - |
Unlevered Free Cash Flow | -346.78 | -366.05 | -63.47 | -67.46 | - |
Free Cash Flow After Leases | -462.44 | -451.07 | -144.06 | -276.78 | -253.82 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 0.85 | 0.85 | - | - | - |
Change in Working Capital | -284.68 | -274.07 | 1.66 | -83.83 | -57.81 |